Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions.

 

The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software.

 

The company was founded in 1949 and is headquartered in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Blue-Chip Stocks to Buy for the Second Half of 2024

2024-07-26
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

DexCom reaches a multi-year low as downgrades follow guidance cut

2024-07-26
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

S&P 500’s Biggest Loser Has a Heart Valve Problem

2024-07-25
Edwards Lifesciences, the largest maker of minimally invasive heart valve replacements, was down 28% on Thursday, the biggest decliner in the S&P 500 index. The steep drop was largely thanks to a slowdown of its transcatheter aortic heart-valve (TAVR) business, which generates roughly two-thirds of revenue. TAVR is a procedure that allows patients to avoid open heart surgery to replace a damaged valve.

Interesting MDT Put And Call Options For September 6th

2024-07-25
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Is Medtronic plc's (NYSE:MDT) Stock On A Downtrend As A Result Of Its Poor Financials?

2024-07-24
It is hard to get excited after looking at Medtronic's (NYSE:MDT) recent performance, when its stock has declined 2.7...

My Dividend Stock Portfolio: New June Dividend Record - 101 Holdings With 22 Buys

2024-07-24
Investment activity remained high in June, focusing on BDCs aiming to increase dividend income by at least $100 each month. Click here for my portfolio picks.

Medtronic (MDT) is a Top-Ranked Value Stock: Should You Buy?

2024-07-23
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

7 Blue-Chip Stocks to Buy on the Dip: July 2024

2024-07-23
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

LeMaitre Vascular: A Small Cap With Best-In-Industry Growth

2024-07-23
LeMaitre Vascular has shown incredible revenue and EPS growth since its IPO. Read why LMAT stock is one of the best small caps in the healthcare sector.

Medtronic (MDT) Stock Sinks As Market Gains: Here's Why

2024-07-22
Medtronic (MDT) closed at $79.30 in the latest trading session, marking a -0.23% move from the prior day.